
01 / 04
Genuine Medicines
Tracked Shipping
Plain Packaging
Order Metadata
ReferenceGH·BORZOMED
AvailabilityIn stock
SourceIndia
Delivery5–10 business days to your country
GH·BORZOMEDAnti-Cancer / Oncology Medicines
Borzomed 2 mg Inj
Bortezomib is a prescription cancer medicine used to treat multiple myeloma, a cancer of the plasma cells in the bone marrow. It is also used for mantle cell lymphoma. It works by blocking the proteasome, which cancer cells need to break down proteins and survive, so the cells die. It is given as an injection under the skin or into a vein by trained healthcare staff, and only under the supervision of a cancer specialist.
Order This Product
Send us a message on WhatsApp with this product name — we'll come back with the price and delivery options for your country.
Description
Bortezomib belongs to a group called proteasome inhibitors, which stop cancer cells from clearing out damaged proteins, causing these proteins to build up and the cells to die. Myeloma cells are especially sensitive to this effect because they produce large amounts of abnormal protein. It is prescribed for newly diagnosed and relapsed multiple myeloma and for mantle cell lymphoma, usually together with other medicines such as dexamethasone, melphalan, lenalidomide, or thalidomide. It is given in treatment cycles, commonly twice a week for two weeks followed by a rest period, and the dose depends on body surface area. The subcutaneous (under the skin) route is often preferred because it causes less nerve damage than the intravenous route. Blood counts, liver function, and nerve symptoms are monitored before and during treatment, and doses may be delayed or reduced when needed. Common side effects include nausea, vomiting, diarrhea, constipation, tiredness, low platelets and white blood cells, and loss of appetite. Peripheral neuropathy, which causes numbness, tingling, burning, or pain in the hands and feet, is a key risk and should be reported early so the dose can be adjusted. It can also cause low blood pressure, fever, and shingles, so antiviral medicine is often given to prevent shingles. Rarely, it can cause serious lung problems, heart problems, liver injury, or a severe blood-clotting condition, so breathlessness, chest pain, or yellow skin or eyes needs urgent medical care. Strong CYP3A4 inhibitors such as ketoconazole and ritonavir, and inducers such as rifampicin and St. John’s wort, can change its levels, and diabetes medicines may need adjustment. It can harm an unborn baby, so effective contraception is advised during treatment and for several months afterward, and breastfeeding should be avoided. Treatment should never be missed, changed, or stopped without the oncology team’s advice.
Specifications
- Composition
- Bortezomib
- Strength
- 2 mg
- Manufacturer
- Medicamen
- Treatment
- Cancer Medicine
- Packaging Type
- Vial
- Packaging Size
- 1 Vial
How this product reaches you
- 1Global Healthcare sources this product from a manufacturer in India. The manufacturer name and country are part of the order record.
- 2It is shipped from India to your address. Carrier and delivery options depend on your country and order size.
- 3Your country's import rules apply — we help you understand them on chat.
